E
Mangoceuticals, Inc. MGRX
$2.04 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -11.18M -8.71M -9.33M -9.13M -9.02M
Total Depreciation and Amortization 1.14M 731.50K 16.00K 22.00K 25.00K
Total Amortization of Deferred Charges 0.00 0.00 464.30K 222.70K --
Total Other Non-Cash Items 3.99M 2.45M 2.75M 2.33M 1.89M
Change in Net Operating Assets -95.30K 660.30K 668.10K 578.10K 921.90K
Cash from Operations -6.15M -4.86M -5.43M -5.98M -6.18M
Capital Expenditure -- -- 0.00 0.00 0.00
Sale of Property, Plant, and Equipment 65.00K 65.00K 65.00K 65.00K --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 65.00K 65.00K 65.00K 65.00K 0.00
Total Debt Issued 62.50K 150.00K 187.50K 187.50K 87.50K
Total Debt Repaid -- -- 0.00 0.00 -167.50K
Issuance of Common Stock 2.28M 1.33M 1.77M 1.77M 2.40M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock 3.80M 2.65M 2.25M 1.50M --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 6.15M 4.13M 4.21M 3.46M 2.32M
Foreign Exchange rate Adjustments -2.20K -9.90K -1.70K -1.20K -100.00
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 61.10K -680.40K -1.16M -2.46M -3.86M